Rituximab, Gemcitabine and Oxaliplatin (R-GEMOX) for Refractory/Relapsed B-cell Lymphoma
Clinical trial NCT00169195 · COMPLETED
Trial details
- NCT number
- NCT00169195
- Sponsor
- Lymphoma Study Association
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-04-01
- Primary completion
- 2012-11-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.